Source record

Matching a cancer chart to trial eligibility

ベンダー

この言語の本文は未訳のため、英語で表示しています。

The source is Tempus’s company website, dated in this index as 1 April 2025, read as a vendor description of trial matching. Flatiron and Deep 6 AI are named as other companies that sell a version of the same job. The page is not an independent study of enrollment. No enrollment rate or days-saved figure is repeated, because those claims are vendor-specific and often omit how many suggestions a coordinator rejects.

Source date: 2025年4月1日 · 年 2025
Evidence label: ベンダー報告
Source type: ベンダー

Citation

Tempus

Tempus. Company website, dated in this index as 1 April 2025. https://www.tempus.com/ Vendor description of clinical data and trial services. Flatiron and Deep 6 AI are named only as other companies selling trial-matching tools. Not an enrollment study.

Key public facts

The cited source is a vendor website, not a peer-reviewed enrollment study.
The tool reads structured fields and sometimes free text, and lists studies a patient might qualify for.
A research coordinator still checks every criterion against the chart.
A match list is not enrollment and not a treatment recommendation.
No enrollment-rate or speed figure is stated.

Original link

Opens the publisher page in a new tab.

Back to the case

教育と市場把握のための条目。医療助言でも推奨でもありません。